Skip to main navigation
Pulse Biosciences, Inc
  • Home
  • Technology
    • Nano-Pulse Stimulation Technology
    • CellFX™ System
    • NPS™ Videos
    • Presentations & Publications
    • Major Discoveries
  • Studies
    • Dermatology
    • Immuno-Oncology
    • Pipeline
    • Our Scientific Experts
  • About Us
    • Pulse Biosciences
    • Management Team
    • Board Of Directors
  • Investors
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Shareholder Services
  • Careers
    • Sr. Product Manager, Device
    • Manufacturing Engineer
    • Research Scientist
    • Clinical Application Specialist
    • Sr. User Interface Engineer
    • Sr. Mechanical R&D Engineer (Disposable Device)
    • Senior Software Engineer (Embedded)
  • Contact Us

Press Releases

Keyword Search

Date Title
5/23/16
Pulse Biosciences Announces Closing of Initial Public Offering
5/17/16
Pulse Biosciences Announces Pricing of Initial Public Offering

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Current page 16

Investor Relations

  • Investors
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • News & Events
    • Press Releases
    • News
    • Events Calendar and Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
  • Shareholder Services
    • Information Request
    • E-mail Alerts

Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts

Pulse Biosciences
Pulse Biosciences, CellFX, Nano-Pulse Stimulation and NPS are trademarks of Pulse Biosciences, Inc.
©2022 Pulse Biosciences, Inc. All Rights Reserved. | WWW2000 Rev F | Privacy Policy | Terms of Use | Code of Conduct | Site Map
CAUTION: Nano-Pulse Stimulation (NPS) technology and the CellFX System are for investigational use only.